¡Libros importados con hasta 50% de descuento!   Ver más

menú

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
Envío gratis
portada Prescription drug data: HHS has issued health privacy and security regulations but needs to improve guidance and oversight: report to congress
Formato
Libro Físico
Idioma
Inglés
N° páginas
42
Encuadernación
Tapa Blanda
Dimensiones
27.9 x 21.6 x 0.2 cm
Peso
0.12 kg.
ISBN13
9781974239993

Prescription drug data: HHS has issued health privacy and security regulations but needs to improve guidance and oversight: report to congress

U. S. Government Accountability Office (Autor) · Createspace Independent Publishing Platform · Tapa Blanda

Prescription drug data: HHS has issued health privacy and security regulations but needs to improve guidance and oversight: report to congress - Office, U. S. Government Accountability

Sin Stock

Reseña del libro "Prescription drug data: HHS has issued health privacy and security regulations but needs to improve guidance and oversight: report to congress"

"Why GAO Did This Study Prescribing medications and filling those prescriptions increasingly relies on the electronic collection of individuals' health information and its exchange among health care providers, pharmacies, and other parties. While this can enhance efficiency and accuracy, it also raises privacy and security concerns. Federal law establishes the authority for the Secretary of HHS to develop standards for protecting individuals' health information (which includes Medicare beneficiaries) and to ensure that covered entities (such as health care providers and pharmacies) and their business associates comply with these requirements. The Medicare Improvements for Patients and Providers Act of 2008 required GAO to report on prescription drug use data protections. GAO's specific objective for this review was to determine the extent to which HHS has established a framework to ensure the privacy and security of Medicare beneficiaries' protected health information when data on prescription drug use are used for purposes other than direct clinical care. To do this, GAO reviewed HHS policies and other related documentation and interviewed agency officials. What GAO Recommends GAO recommends that HHS issue de-identification guidance and establish a plan for a sustained audit capability. HHS generally agreed with both recommendations but disagreed"

Opiniones del libro

Ver más opiniones de clientes
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes